Clinical Case Reports (Sep 2022)
Uterine malignant leiomyosarcoma associated with high levels of serum beta‐human chorionic gonadotropin: A case report
Abstract
Abstract We present the case of a 54‐year‐old woman diagnosed with uterine leiomyosarcoma that produced beta‐human chorionic gonadotropin (β‐hCG), evident by both serum and immunohistologic examination. Based on this and similar cases from the available literature, β‐hCG‐producing sarcomas tend to have poorer prognosis, indicating that β‐hCG could potentially be used as a marker of disease status and response to the therapy; however, this association is inconsistent and should be further investigated.
Keywords